Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]
Innovative enterprise platform for clinical cross-omics now also accessible via high-performance cloud computing services Microsoft Azure and Amazon Web Services Basel, Switzerland Genedata, a leading provider of advanced software solutions for biopharmaceutical research and development (R&D), today announced that Genedata ProfilerTM, its leading enterprise software platform for omics-based profiling of patients in translational and clinical […]
Palo Alto, California — PREMIER Biosoft today announced the release of SimGlycan 5.90. The new version is about five times faster than the last version and allows for more accurate glycan identification with the updated algorithms. Additionally, SimGlycan now offers an intuitive data analysis automation interface. The key features included are: More Efficient LC-MS Peak Picking Algorithm: Accurate […]
RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is intended for prognostic use […]
Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]
BC Platforms, a world leader in genomic data management and analysis solutions, announces co-operation with FinnGen program. FinnGen is a unique study that has been launched in Finland. Program will deepen our understanding about the origins of diseases and their treatment. The FinnGen study plans to tap into 500 000 unique blood samples collected by […]
Community-owned database empowers individuals with cryptocurrency for contributing genomic data SAN DIEGO — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included several individual investors and former executives from Illumina ILMN 0.34%, the world leader in DNA sequencing and […]
STRmix™ – the sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret – has been used in a case in which a Brooklyn, NY man was convicted of murder for slashing the throat of his estranged wife. WASHINGTON STRmix™ – the sophisticated forensic software used to resolve […]
New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has received a payment from Sanofi for reaching a major milestone in its multi-year, multi-target drug discovery collaboration. The project in which the milestone was achieved is one of several programs that Schrödinger is […]
DNAnexus launches pilot of turn-key solution for deploying computationally intensive deep learning technology focused on genomic variation analysis MOUNTAIN VIEW, Calif.–DNAnexus, the global leader in genome informatics and data management, today announced the availability of the DeepVariant bioinformatics tool on the DNAnexus Platform. Developed by researchers at Google, DeepVariant is a deep learning technology that […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
